Financial Performance - Net profit attributable to shareholders rose by 27.01% to CNY 411,013,663.44 for the first nine months of the year[6] - Operating revenue for the first nine months reached CNY 1,360,205,190.98, marking a 38.39% increase year-on-year[6] - The company reported a net profit of CNY 395,617,744.04 after deducting non-recurring gains and losses, up 31.24% year-on-year[6] - Basic and diluted earnings per share increased by 27.27% to CNY 0.98[7] - The weighted average return on equity rose by 3.98 percentage points to 24.11%[7] - Total operating revenue for Q3 2018 reached ¥511,901,681.70, an increase of 27.9% compared to ¥400,373,004.01 in Q3 2017[28] - Net profit for the first nine months of 2018 was ¥457,892,823.18, compared to ¥350,147,314.94 for the same period in 2017, reflecting a growth of 30.8%[28] - The net profit attributable to the parent company for Q3 2018 was ¥164.37 million, up 24.2% from ¥132.18 million in Q3 2017[30] - The total profit for Q3 2018 reached ¥186.76 million, a rise of 20.5% compared to ¥155.14 million in Q3 2017[30] - The net profit for Q3 2018 was CNY 162,099,218.42, an increase of 17.9% compared to CNY 137,489,262.62 in Q3 2017[34] Revenue and Costs - Total operating costs for Q3 2018 were ¥329,528,155.88, up 31.2% from ¥251,052,169.86 in Q3 2017[28] - The company's operating revenue for Q3 2018 was approximately ¥466.88 million, an increase of 20.3% compared to ¥387.82 million in Q3 2017[33] - The company's total operating costs for Q3 2018 were ¥177.33 million, an increase of 19.98% from ¥147.75 million in Q3 2017[33] - Sales expenses for Q3 2018 were ¥58.08 million, up 25.7% from ¥46.18 million in Q3 2017[33] Assets and Liabilities - Total assets increased by 11.53% to CNY 2,439,427,651.88 compared to the end of the previous year[6] - Total assets as of September 30, 2018, amounted to ¥2,439,427,651.88, an increase of 11.5% from ¥2,187,315,823.04 at the beginning of the year[21] - Total liabilities increased to ¥632,244,984.29, up 27% from ¥497,845,838.05 at the beginning of the year[21] - Current liabilities totaled ¥550,060,559.58, a rise of 28.6% compared to ¥427,685,096.63 at the start of the year[21] - Non-current assets reached ¥1,438,333,911.77, an increase of 14.2% from ¥1,258,980,679.29 at the beginning of the year[25] Cash Flow - The net cash flow from operating activities increased by 24.19% to CNY 433,802,021.69 compared to the same period last year[6] - The net cash flow from operating activities for the first nine months of 2018 was CNY 433,802,021.69, compared to CNY 349,301,211.22 in the previous year, reflecting a growth of 24.2%[37] - Cash inflow from financing activities amounted to ¥61,955,368.58, an increase from ¥37,800,000.00 in the previous year, marking a growth of about 64.0%[40] - Cash outflow from investment activities totaled ¥1,760,893,887.24, down from ¥3,417,943,625.59 in the previous year, indicating a decrease of approximately 48.6%[39] - The cash outflow from investing activities for the first nine months of 2018 was CNY 1,727,232,195.41, compared to CNY 3,394,217,224.79 in the previous year, indicating a decrease of 49.0%[37] Shareholder Information - The total number of shareholders reached 9,675 by the end of the reporting period[11] - The largest shareholder, Zhengzhou Antu Industrial Co., Ltd., holds 67.49% of the shares, with 283,462,200 shares pledged[11] Research and Development - Research and development expenses increased by 45.38% to RMB 143,888,780.12, compared to RMB 98,972,422.26 in the previous year[14] - Research and development expenses for Q3 2018 amounted to ¥23.44 million, representing a 21.1% increase from ¥19.29 million in Q3 2017[33] Government Subsidies - The company received government subsidies totaling CNY 7,557,804.44, closely related to its normal business operations[8] Financial Expenses and Income - The company’s financial expenses increased by 61.27% to RMB 2,524,826.72, primarily due to higher interest expenses on bank loans[14] - The company’s investment income decreased by 34.33% to RMB 10,936,029.07 from RMB 16,653,579.57, mainly due to reduced bank wealth management income[15]
安图生物(603658) - 2018 Q3 - 季度财报